Time-course microarray analysis for identifying candidate genes involved in obesity-associated pathological changes in the mouse colon by Yun Jung Bae et al.
Bae et al. Genes & Nutrition  (2016) 11:30 
DOI 10.1186/s12263-016-0547-xRESEARCH Open AccessTime-course microarray analysis for
identifying candidate genes involved in
obesity-associated pathological changes in
the mouse colon
Yun Jung Bae1†, Sung-Eun Kim2†, Seong Yeon Hong2, Taesun Park3,6, Sang Gyu Lee4, Myung-Sook Choi5,6
and Mi-Kyung Sung2,6*Abstract
Background: Obesity is known to increase the risk of colorectal cancer. However, mechanisms underlying the
pathogenesis of obesity-induced colorectal cancer are not completely understood. The purposes of this study
were to identify differentially expressed genes in the colon of mice with diet-induced obesity and to select
candidate genes as early markers of obesity-associated abnormal cell growth in the colon.
Methods: C57BL/6N mice were fed normal diet (11% fat energy) or high-fat diet (40% fat energy) and were
euthanized at different time points. Genome-wide expression profiles of the colon were determined at 2, 4, 8,
and 12 weeks. Cluster analysis was performed using expression data of genes showing log2 fold change of ≥1
or ≤−1 (twofold change), based on time-dependent expression patterns, followed by virtual network analysis.
Results: High-fat diet-fed mice showed significant increase in body weight and total visceral fat weight over
12 weeks. Time-course microarray analysis showed that 50, 47, 36, and 411 genes were differentially expressed
at 2, 4, 8, and 12 weeks, respectively. Ten cluster profiles representing distinguishable patterns of genes
differentially expressed over time were determined. Cluster 4, which consisted of genes showing the most
significant alterations in expression in response to high-fat diet over 12 weeks, included Apoa4 (apolipoprotein
A-IV), Ppap2b (phosphatidic acid phosphatase type 2B), Cel (carboxyl ester lipase), and Clps (colipase, pancreatic),
which interacted strongly with surrounding genes associated with colorectal cancer or obesity.
Conclusions: Our data indicate that Apoa4, Ppap2b, Cel, and Clps are candidate early marker genes associated with
obesity-related pathological changes in the colon. Genome-wide analyses performed in the present study provide
new insights on selecting novel genes that may be associated with the development of diseases of the colon.
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Obesity is a major global health problem that is closely
associated with non-communicable diseases with rapidly
increasing incidence, including type 2 diabetes, hyper-
tension, cardiovascular diseases, and some cancers [1].
Excess energy intake contributes to abnormal intermedi-
ate conditions such as hyperinsulinemia, hyperglycemia,
and dyslipidemia, leading to the development of obesity-
related metabolic complications [2].
Epidemiological evidence indicates that excess body fat
is associated with an increased risk of colorectal cancer
(CRC) [3]. The risk of CRC increases by 7% with an in-
crease in body mass index (BMI) by 2% [4]. Experimen-
tal studies also indicate that diet-induced obesity causes
pathological changes in the colon. The number of polyps
is significantly higher, and the areas of hyperplasia in the
colonic mucosa and inflammatory foci throughout the
gastrointestinal tract are broader in high-fat diet (HFD)-
fed mice than in control mice [5]. Mice fed HFD for two
third of their life span and not treated with carcinogenic
chemicals show substantially higher incidence and multi-
plicity of colon tumor than mice fed a control diet [6].
Increased circulating concentrations of insulin and leptin
are linked to abnormal hyperproliferation of colorectal
tissue and inflammation possibly by controlling tran-
scription factors involved in the expression of cell
growth-regulating molecules [7–12]. Whole-colon prote-
omic analyses of wild-type and leptin-deficient ob/ob
mice suggest that 40 differently expressed proteins are
associated with obesity-related pathological changes in
the colon [13]. However, to our knowledge, no study has
identified candidate molecules involved in obesity-
associated pathological changes in the colon of HFD-fed
mice. Moreover, limited information is available on
mechanisms underlying the pathophysiological changes
in the colon tissue of obese animals.
Interactions between nutritional factors and cellular
events in the biological system are extremely compli-
cated. Traditional nutrition research design involving
one or two molecular targets often cannot explain
phenotypic changes induced by missing responses of
other important targets to nutritional stimuli. Recent de-
velopments in genome-wide analyses have been used to
identify biomarkers that respond to nutritional interven-
tion such as HFD. Several studies indicate that diet-
induced obesity changes gene expression patterns in
various tissues. Expression of key adipose transcription
factors that regulate adipogenesis and insulin sensitivity,
including leptin, resistin, uncoupling protein-2, tumor
necrosis factor-alpha (TNF-α), CCAAT/enhancer-bind-
ing protein α, peroxisome proliferator-activated receptor,
sterol regulatory element-binding transcription factor 1,
and hydroxysteroid 11-beta dehydrogenase 1, is changed
in the gonadal fat tissue of HFD-fed animals [14, 15].HFD also alters the expression of interferon-gamma,
interleukin-4, interleukin-10, interleukin-12, and TNF-α
in the liver tissue [16]. Despite a strong association be-
tween obesity and pathophysiological changes in the small
intestine and colon that lead to the development of ulcera-
tive colitis, irritable bowel syndrome (IBD), and CRC, only
few studies have examined the association between diet-
induced obesity and gene expression pattern of the intes-
tinal tissue [17, 18]. A recent study reported substantial
changes in lipid metabolism-related gene expression in
the small intestine of animals fed long-chain fatty acids of
marine origin [19]. Our present study is the first to report
global transcriptional changes at different time points dur-
ing the development of diet-induced obesity in the colon
of HFD-fed animals. In addition, we performed bioinfor-
matics analyses to identify candidate early marker genes
that might be involved in obesity-related pathological
events such as CRC and IBD.
Methods
Animals
This study was performed in accordance with the Guide
for the Care and Use of Laboratory Animals developed
by the Institute of Laboratory Animal Resources of the
National Research Council [20] and was approved by the
Institutional Animal Care and Use Committee of Yonsei
University in Seoul, Republic of Korea (Permit No.:
2010-0039). Eighty 5-week-old male C57BL/6N mice
(Orient, Gyeonggi-do, Korea) were housed in a
temperature (21 ± 2 °C)- and humidity (50 ± 5%)-con-
trolled room with a 12-h light/12-h dark cycle. The mice
were fed a commercial diet (Purina, St. Louis, MO,
USA) for 1 week and were randomly assigned to receive
normal diet (ND, n = 40) and HFD (n = 40). HFD con-
tained 200 g fat/kg (170 g lard plus 30 g corn oil) and
1% cholesterol by weight. It was formulated to provide
40% of the total energy from fat by replacing carbohy-
drates with lard and corn oil; however, it contained the
same amount of vitamins and minerals per kilocalorie as
those in the ND. Compositions of the experimental diets
are presented in Additional file 1: Table S1. The mice
were fed the experimental diets and water ad libitum.
Food intake of the mice was recorded daily, and their
body weights were measured every 3 days. Ten mice per
group were sacrificed at 2, 4, 8, and 12 weeks of feeding
the experimental diets by fasting them overnight and by
anesthetizing them with diethyl ether. Their colons were
laid flat on a glass plate, and the colonic mucosa was
scraped using a glass slide. The colon samples were
stored at −80 °C until their use.
Time-course microarray analysis
Total RNA was isolated from the colon tissue of each
mouse, using TRIzol (Invitrogen Life Technologies,
Fig. 1 Schematic flow chart of the study design representing time-
course microarray analyses (2, 4, 8, and 12 weeks) of the colon tissue
of C57BL/6N mice fed normal or high-fat diet
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column (Qiagen, Valencia, CA, USA), according to the
manufacturer’s protocols. RNA purity and integrity were
evaluated by denaturing gel electrophoresis, OD260/
OD280 ratio, and analyzed on the Agilent 2100 Bioanaly-
zer (Agilent Technologies, Palo Alto, CA, USA). The
RNA Integrity Number (RIN) score was generated on
the Agilent software, and the average RIN score of all
samples used for microarray analysis was 8.5 ± 0.9
(mean ± SD). To reduce individual variability in gene ex-
pression, identical amounts of total colonic RNA were
pooled from 10 mice in each experimental group and a
pooled RNA sample representing the ND and HFD
group at 2, 4, 8, and 12 weeks was subjected to micro-
array experiment as described previously [21]. Total
RNA was amplified and purified using the Illumina®
TotalPrepTM-96 RNA Amplification Kit (Ambion,
Austin, TX, USA) to produce biotinylated complementary
RNA (cRNA), according to the manufacturer’s instruc-
tions. The cRNA obtained was quantified using an ND-
1000 Spectrophotometer (NanoDrop, Wilmington, DE,
USA). The biotinylated cRNA was hybridized onto the
Illumina Mouse WG-6 v2.0 Expression BeadChip (Illu-
mina, Inc., San Diego, CA, USA) containing 45,281 probes
representing 30,584 genes. After washing and staining, the
BeadChip was scanned with the Illumina Bead Array
Reader Confocal Scanner according to the manufacturer’s
instructions. Raw data were exported and analyzed using
BeadStudio v3.1.3 (Gene Expression Module v3.3.8; Illu-
mina). All the data analyses and visualization of differen-
tially expressed genes were conducted using ArrayAssist®
(Stratagene, La Jolla, CA, USA). Values are expressed as
log2 fold change and were obtained by comparing the gene
expression profiles of HFD-fed mice with those of ND-fed
mice. Genes showing log2 fold change of ≥1 or ≤−1 (fold
change of ≥2 or ≤−2) were selected, and functional ana-
lysis was performed using PANTHER database system
(www.patherdb.org). Clustering analysis was performed
using genes showing similar expression trends over time.
MultiExperiment Viewer program was used to evaluate K-
means algorism [22]. A gene cluster showing the highest
fluctuation over time was selected, and biological pro-
cesses associated with these HFD-responsive genes over
time were analyzed using Database for Annotation,
Visualization and Integrated Discovery (DAVID, https://
david.ncifcrf.gov/) [23]. Virtual interaction network-
targeted genes in the selected cluster were determined
using Michigan Molecular Interactions software [24, 25].
In this network, genes that interacted with genes in the
protein interaction data consolidated from seven public
databases (Biomolecular Interaction Network Database
[BIND], Database of Interacting Proteins [DIP], IntAct
molecular interaction database [IntAct], Molecular INTer-
action database [Mint], Reactome, CCSB InteractomeDatabase [CCSB], and Human Protein Reference Database
[HPRD]) were sorted [26–28] (Fig. 1).
Real-time quantitative polymerase chain reaction analysis
Real-time quantitative polymerase chain reaction (qPCR)
was conducted to validate microarray data of several dif-
ferentially expressed genes that were selected based on
the clustering and network analyses and that were asso-
ciated with the biological function of interest, including
CRC and obesity. Template RNA isolated from the colon
tissue was reverse transcribed using Superscript™ II RT-
PCR System (Invitrogen, Karlsruhe, Germany), accord-
ing to the manufacturer’s instructions, for performing
dT 20-primed complementary DNA (cDNA) synthesis.
Next, real-time qPCR was performed using an ABI
PRISM 7900HT Sequence Detection System (Applied
Biosystems, Foster City, CA, USA) in 384-well microtiter
plates containing a final reaction volume of 10 μl. Four
primer/TaqMan probe combinations were designed
based on the following sequences obtained from an
NCBI public database: Apoa4, Mm00431814_m1; Cel,
Mm00486975_m1; Clps, Mm00517960_m1; and Ppap2b,
Mm00504516_m1. Amplifications were performed using
the following protocol: initial template denaturation at
95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s
and 60 °C for 1 min. All the samples were amplified
in triplicate, and data were analyzed using Sequence
Detector software (Applied Biosystems).
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Differences among mice in the two dietary groups were
analyzed by Student’s t test, with SAS 9.4 (SAS Institute,
Inc., Cary, NC, USA). Results were considered statisti-
cally significant if two-tailed P values were <0.05.
Results
Time-course of changes in body weight, visceral fat pad
weight, and food efficiency ratio during the development
of diet-induced obesity
C57BL/6N mice fed HFD for 2 weeks gained signifi-
cantly more weight than mice fed ND (P < 0.001; Fig. 2a).
At the end of 12 weeks, HFD-fed mice gained 22.3 g
weight compared with ND-fed mice that gained 15.3 g
weight (P < 0.001). Total visceral fat weight of HFD-fed
mice was higher than that of ND-fed mice at as early as
2 weeks of the experiment (P < 0.001; Fig. 2b). Food effi-
ciency ratio also increased significantly for HFD-fed
mice at all the time points compared with that for ND-
fed mice (P < 0.001; Additional file 2: Table S2).
Time-course of transcriptional changes in the colon tissue
during the development of diet-induced obesity
Two-dimensional hierarchical clustering showed different
gene expression patterns at different time points in HFD-
and ND-fed C57BL/6N mice (Additional file 3: Figure S1).
The number of HFD-responsive genes at different time
points in the colon of C57BL/6N mice is presented in
Table 1. We found that 41, 35, 1, and 33 genes were up-
regulated and 9, 12, 35, and 378 genes were downregu-
lated at 2, 4, 8, and 12 weeks, respectively, in response to
HFD (Table 1). Genes affected by HFD at different time
points in the colon tissue of C57BL/6N mice are listed in
Additional file 4: Table S3.
Functional analysis was performed using PANTHER
classification system to identify biological processes as-
sociated with HFD-responsive genes in the colon tissue
of mice. The biological processes associated with HFD-
responsive genes in the colon tissue of mice are pre-
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Fig. 2 Time-course changes in body weight and total visceral fat weight d
visceral fat weight. Data are presented as mean ± SEM (n = 10/diet group).
mice in the normal diet groupbiological processes, including immunity and defense;
nucleoside, nucleotide, and nucleic acid metabolism;
signal transduction; and cell cycle (Table 2). Biological
processes associated with HFD-responsive genes at dif-
ferent time points in the colon tissue of C57BL/6N mice
are listed in Additional file 5: Table S4.
We also identified HFD-responsive genes showing log2
fold change of ≥1 or ≤−1 (corresponding to a fold change
of ≥2 or ≤−2) at multiple time points (>3 times) over
12 weeks (Table 3). Most HFD-responsive genes were asso-
ciated with digestive enzymes such as trypsin, carboxypepti-
dase, and amylase. Overall, these genes were upregulated at
weeks 2 and 4 and were downregulated at week 12 in
HFD-fed mice compared with those ND-fed mice (Table 3).
Cfd, complement factor D (adipsin), was downregulated at
weeks 4, 8, and 12 in HFD-fed mice. Adipsin is suggested
to activate an alternative complement pathway for inducing
natural defense against infectious agents and red cell lysis
and to regulate systemic energy balance [29, 30]. A previous
study reported that adipsin expression in the small intestine
is a potential marker of changes in normal intestinal epithe-
lial differentiation [31]. Pla2g1b, pancreatic phospholipase
A2, was upregulated at weeks 2 and 4 and was downregu-
lated at week 12 in HFD-fed mice. Pancreatic phospholip-
ase A2 catalyzes the release of fatty acids from dietary
phospholipids. Diet is the ultimate source of arachidonic
acid present in cellular phospholipids, which serve as pre-
cursors of eicosanoid signaling molecules and are involved
in inflammation, cell proliferation, and colorectal carcino-
genesis. Arachidonic acid is metabolized by PTGS (COX)/
LOX pathway to prostaglandins and leukotrienes, which
are associated with carcinogenesis, specifically of colonic
carcinogenesis [32, 33].
Cluster and network analyses for identifying candidate
early marker genes associated with diet-induced obesity
We next selected a cluster of HFD-responsive genes
showing the highest fluctuation over time. Ten separate
cluster profiles showing distinguishable patterns of genes
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*P < 0.01 and **P < 0.001 indicate significant difference compared with
Table 1 The number of differentially expressed genes affected
by the high-fat diet at different time points in the colon tissue
of C57BL/6N mice
Weeks Upregulated Downregulated Total
2 41 9 50
4 35 12 47
8 1 35 36
12 33 378 411
Differentially expressed genes indicate genes showing a log2 fold change of ≥1
or ≤−1 (fold change of ≥2 or ≤−2) based on the comparison between high-fat
diet- and normal diet-fed mice at each time point (P < 0.05)
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lows: cluster 1, 45 genes; cluster 2, 32 genes; cluster 3,
17 genes; cluster 4, 44 genes; cluster 5, 35 genes; cluster
6, 24 genes; cluster 7, 8 genes; cluster 8, 78 genes; clus-
ter 9, 103 genes; and cluster 10, 76 genes. Virtual net-
work analysis was performed for genes in cluster 4 that
showed the most significant alterations in response to
HFD over 12 weeks. The genes in cluster 4 are listed in
Table 4. Gene ontology (GO) biological pathway ana-
lysis showed that genes in cluster 4 were involved in
proteolysis, lipid catabolic process, digestion, defense
response, and acute-phase response (Table 5). Results
of the virtual network analysis showed that Apoa4
(apolipoprotein A-IV), Ppap2b (phosphatidic acid phos-
phatase type 2B), Cel (carboxyl ester lipase), and Clps
(colipase, pancreatic) strongly interacted with sur-
rounding genes (Fig. 4). Previous studies have reported
that these core genes are involved in pathological
changes associated with CRC or obesity [34–36]. Re-
sults of microarray-based analysis of the expression of
these genes were confirmed by performing real-time
qPCR at each time point. Overall, the changes in the
transcription profiles of Apoa4, Ppap2b, Cel, and Clps
determined by real-time qPCR were consistent with the
results of microarray analysis (Fig. 5). The direction of
change between the two analyses was consistent for the
significantly regulated genes except Ppap2b at week 4
(log2 fold change −0.13) and Cel at week 8 (log2 fold
change 0.04).Table 2 The biological processes associated with high-fat diet-respo
Biological process No. of
total probes
Immunity and defense 2634




FDR false discovery rate using a Benjamini and Hochberg multiple testing correctio
database systemDiscussion
In the present study, we determined global transcrip-
tional changes at different time points during the devel-
opment of diet-induced obesity in the colon of mice. We
also performed bioinformatics analyses to identify candi-
date genes that could be used as early markers of
obesity-related pathological events. Diet-induced obesity
is associated with many chronic diseases, including CRC
and IBD. Epidemiological studies have reported a si-
gnificant association between BMI and colon cancer
(HR, 1.05; 95% CI, 1.02–1.09) [37]. Obese C57BL/6 mice
develop colonic epithelial hyperplasia, and the risk of
colon cancer increases by 42% after long-term (18 months)
western-style diet feeding [38, 39]. A recent study indi-
cated that HFD increased the number of polyps in the
colon and the area of hyperplasia in the mucous mem-
brane tissue of the colon [5]. We previously observed that
HFD-fed mice (45% total calories from fat) developed
two-times more number of colonic tumors than ND-fed
mice possibly because of adipokine-mediated signaling of
phosphatidylinositol 3-kinase/Akt pathway [40]. However,
limited information is available on mechanisms underlying
the associations between obesity and pathophysiological
changes in the colon.
In the present study, genes showing differential ex-
pression in response to HFD were subjected to cluster-
ing and networking analyses. Clustering algorithms are
frequently used to group genes with similar expression
profiles [41]. This facilitates the visualization of coex-
pressed genes and allows the identification of genes that
concurrently respond to stimuli. We clustered genes that
were expressed differentially over time into 10 patterns.
Of the 10 clusters, cluster 4 included genes that were
the most responsive to HFD. Many of these genes were
upregulated after the initiation of HFD and were down-
regulated gradually as the mice became obese. We pos-
tulated that these genes could be used as early markers
of the initiation of metabolic changes in the colon.
We found that genes in cluster 4 were involved in prote-
olysis, lipid catabolic process, digestion, defense response,
and acute-phase response. These results indicate that HFDnsive genes at week 12 in the colon tissue of C57BL/6N mice
No. of genes P value FDR
Up Down
0 28 <0.0001 0.001
4 55 <0.001 0.005
1 60 0.014 0.131
1 16 0.039 0.262
2 37 0.047 0.262
n, P value modified Fisher’s exact P value calculated by PANTHER
Fig. 3 Clustering analysis of genes expressed differentially in response to high-fat diet over 12 weeks in the colon tissue of C57BL/6N mice
Table 3 Genes expressed differentially in response to high-fat diet at multiple time points in the colon tissue of C57BL/6N mice
Symbol Accession Definition Log2 fold change
Week 2 Week 4 Week 8 Week 12
AI747448 NM_001033199.2 Expressed sequence AI747448 (AI747448), mRNA. 1.14 −2.62 −1.88
Amy2 NM_009669.1 Amylase 2, pancreatic (Amy2), mRNA. 3.92 1.91 −4.93
Apoa4 NM_007468.2 Apolipoprotein A-IV (Apoa4), mRNA. 1.06 −1.20 −1.13
Cel NM_009885.1 Carboxyl ester lipase (Cel), mRNA. 3.99 1.26 −3.88
Cfd NM_013459.1 Complement factor D (adipsin) (Cfd), mRNA. −1.93 −1.17 −1.19
Cpa2 NM_001024698.2 Carboxypeptidase A2, pancreatic (Cpa2), mRNA. 2.95 1.01 −1.91
Cpb1 NM_029706.1 Carboxypeptidase B1 (tissue) (Cpb1), mRNA. 4.35 1.31 −4.14
Ctrb1 NM_025583.1 Chymotrypsinogen B1 (Ctrb1), mRNA. 4.08 1.64 −2.84
Ctrl NM_023182.2 Chymotrypsin-like (Ctrl), mRNA. 4.04 1.01 −3.52
Ela2a NM_007919.2 Elastase 2A (Ela2a), mRNA. 5.52 1.08 −6.00
Ela3b NM_026419.1 4.62 1.22 −4.12
LOC100040233 XM_001474605.1 Predicted: similar to trypsinogen 15 (LOC100040233), mRNA. 3.23 1.27 −2.06
Pla2g1b NM_011107.1 Phospholipase A2, group IB, pancreas (Pla2g1b), mRNA. 3.79 1.34 −2.86
Rnase1 NM_011271.2 Ribonuclease, RNase A family, 1 (pancreatic) (Rnase1), mRNA. 4.27 1.29 −3.58
Try10 NM_001038996.1 Trypsin 10 (Try10), mRNA. 3.73 1.55 −2.84
Try4 NM_011646.5 Trypsin 4 (Try4), mRNA. 4.72 1.34 −3.67
Log2 fold change of ≥1 or≤−1 corresponds to a fold change of ≥2 or ≤−2, respectively, based on a comparison between high-fat diet- and normal diet-fed mice
at each time point (P < 0.05)
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Table 4 Genes in cluster 4









1810033M07Rik NM_026983.1 RIKEN cDNA 1810033M07 gene (1810033M07Rik), mRNA. 1.30 0.67 0.22 −0.90
1810049H19Rik NM_001003405.1 RIKEN cDNA 1810049H19 gene (1810049H19Rik), mRNA. 4.62 1.44 0.41 −3.66
2900060B14Rik 1.38 0.07 0.11 −0.36
Amy2 NM_009669.1 Amylase 2, pancreatic (Amy2), mRNA. 3.92 1.91 0.22 −4.93
Amy2-2 NM_001042711.2 Amylase 2-2, pancreatic (Amy2-2), mRNA. 4.02 0.44 0.82 −5.93
Apoa4 NM_007468.2 Apolipoprotein A-IV (Apoa4), mRNA. 1.06 0.57 −1.20 −1.13
Cel NM_009885.1 Carboxyl ester lipase (Cel), mRNA. 3.99 1.26 0.04 −3.88
Clps NM_025469.2 Colipase, pancreatic (Clps), mRNA. 2.28 0.49 −0.11 −0.70
Cpa1 XM_284174.1 4.89 0.78 0.15 −4.54
Cpa2 NM_001024698.2 Carboxypeptidase A2, pancreatic (Cpa2), mRNA. 2.95 1.01 0.18 −1.91
Cpb1 NM_029706.1 Carboxypeptidase B1 (tissue) (Cpb1), mRNA. 4.35 1.31 0.02 −4.14
Ctrb1 NM_025583.1 Chymotrypsinogen B1 (Ctrb1), mRNA. 4.08 1.64 0.04 −2.84
Ctrl NM_023182.2 Chymotrypsin-like (Ctrl), mRNA. 4.04 1.01 −0.01 −3.52
Cuzd1 NM_008411.3 CUB and zona pellucida-like domains 1 (Cuzd1), mRNA. 1.70 0.72 −0.04 −1.25
Cygb NM_030206.1 Cytoglobin (Cygb), mRNA. 0.12 −0.15 −0.51 −1.28
EG386551 NM_001003664.1 Predicted gene, EG386551 (EG386551), mRNA. 4.43 1.48 0.28 −3.41
EG436523 NM_001038997.1 Predicted gene, EG436523 (EG436523), mRNA. 3.28 1.50 0.15 −1.97
Ela1 NM_033612.1 Elastase 1, pancreatic (Ela1), mRNA. 2.04 0.61 0.21 −0.87
Ela2a NM_007919.2 Elastase 2A (Ela2a), mRNA. 5.52 1.08 0.60 −6.00
Ela3b NM_026419.1 4.62 1.22 0.04 −4.12
Golga2 NM_133852.2 Golgi autoantigen, golgin subfamily a, 2 (Golga2), transcript variant 1, mRNA. 1.21 0.03 −0.59 −0.91
Gp2 NM_025989.1 Glycoprotein 2 (zymogen granule membrane) (Gp2), mRNA. 3.78 0.91 −0.15 −2.07
Hamp2 NM_183257.1 Hepcidin antimicrobial peptide 2 (Hamp2), mRNA. 1.00 1.00 −0.29 −0.53
LOC100040233 XM_001474605.1 Predicted: similar to trypsinogen 15 (LOC100040233), mRNA. 3.23 1.27 0.04 −2.06
LOC100047162 XM_001477552.1 Predicted: similar to immunoglobulin kappa-chain (LOC100047162), mRNA. 0.62 0.51 −0.09 −1.40
LOC272683 XM_195289.1 0.32 0.07 −0.36 −1.03
LOC636875 XM_992953.1 Predicted: similar to Ig kappa chain V-V region L7 precursor (LOC636875),
mRNA.
3.00 −0.33 0.16 −1.15
LOC636944 XM_912513.1 Predicted: similar to Ig kappa chain V-V region K2 precursor (LOC636944),
mRNA.
1.04 0.69 0.24 −0.14
LOC669053 XM_972773.1 Predicted: similar to Ig kappa chain V-V region MPC11 precursor
(LOC669053), mRNA.
0.30 0.62 −0.96 −1.42
LOC674114 XM_975388.1 Predicted: similar to Ig heavy chain V region 5-84 precursor (LOC674114),
mRNA.
1.15 0.14 0.26 0.04
Pdia2 NM_001081070.1 Protein disulfide isomerase associated 2 (Pdia2), mRNA. 2.89 0.81 0.09 −1.97
Pitx2 NM_001042502.1 Paired-like homeodomain transcription factor 2 (Pitx2),
transcript variant 3, mRNA.
0.48 0.56 −1.81 −2.20
Pitx2 NM_011098.3 Paired-like homeodomain transcription factor 2 (Pitx2),
transcript variant 2, mRNA.
0.40 0.45 −1.17 −1.72
Pla2g1b NM_011107.1 Phospholipase A2, group IB, pancreas (Pla2g1b), mRNA. 3.79 1.34 −0.02 −2.86
Pnlip NM_026925.3 Pancreatic lipase (Pnlip), mRNA. 4.78 0.75 0.20 −4.79
Pnliprp1 NM_018874.2 Pancreatic lipase related protein 1 (Pnliprp1), mRNA. 4.79 0.58 1.00 −4.00
Ppap2b NM_080555.2 Phosphatidic acid phosphatase type 2B (Ppap2b), mRNA. −0.01 −0.13 −0.43 −1.12
Prss3 NM_011645.1 Protease, serine, 3 (Prss3), mRNA. 0.87 1.02 0.06 −0.25
Reg1 NM_009042.1 Regenerating islet-derived 1 (Reg1), mRNA. 4.03 0.59 −0.02 −3.41
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Rnase1 NM_011271.2 Ribonuclease, RNase A family, 1 (pancreatic) (Rnase1), mRNA. 4.27 1.29 0.22 −3.58
Saa3 NM_011315.3 Serum amyloid A 3 (Saa3), mRNA. 0.24 −0.16 −0.46 −1.40
Serpina3n NM_009252.2 Serine (or cysteine) peptidase inhibitor, clade A, member
3N (Serpina3n), mRNA.
0.19 −0.38 −0.35 −1.02
Tff2 NM_009363.3 Trefoil factor 2 (spasmolytic protein 1) (Tff2), mRNA. 2.84 0.81 0.15 −2.18
Try10 NM_001038996.1 Trypsin 10 (Try10), mRNA. 3.73 1.55 0.09 −2.84
Try4 NM_011646.5 Trypsin 4 (Try4), mRNA. 4.72 1.34 0.15 −3.67
Log2 fold change of ≥1 or ≤−1 corresponds to a fold change of ≥2 or ≤−2, respectively, based on a comparison between high-fat diet- and normal diet-fed mice
at each time point (P < 0.05)
Bae et al. Genes & Nutrition  (2016) 11:30 Page 8 of 12upregulated the expression of genes involved in lipid catab-
olism and that these genes were downregulated over time
possibly due to interactions with other compensatory and/
or adaptive mechanisms. Extracellular proteolysis is critical
for tumor growth [42]. Trypsin activates protease-activated
receptor-2 (PAR-2) and increases COX-2 expression
through PAR-2 in Caco-2 cells [43]. These proteolytic activ-
ities may promote tumor cell growth and invasion, suggest-
ing that HFD increases the risk of tumor development by
facilitating proteolytic activity. Oxidative stress and gene–
environment interactions play a significant role in the de-
velopment of colon cancer [44]. Oxidative stress results
from an imbalance in the production of reactive oxygen
species and cellular antioxidant defense system. In the
present study, genes associated with defense response
tended to be downregulated over time during HFD admin-
istration and before colon cancer initiation. This result sug-
gests that continuous HFD administration affects defense
mechanisms, which in turn may increase the risk of CRC.
For further analysis, genes in cluster 4 were subjected to
network analysis by using BIND, DIP, IntAct, Mint, Reac-
tome, CCSB, and HPRD protein–protein interaction data-
bases. Among the genes in cluster 4, four genes showing
the most significant relationship with surrounding genes
were selected and their expression was verified. Previous
studies indicate that these four genes are associated with
pathological changes in the colon or with obesity. APOA4






Proteolysis 1034 15 Prss3, Ela3b, Ctrb1, Cpa2, Try10, Ela2a,
LOC100040233, Ctrl, Try4, Cuzd1, Cpb1
Lipid catabolic
process
134 5 Clps, Pla2g1b, Cel, Pnlip, Pnliprp1
Digestion 26 3 Clps, Ctrb1, Pnlip
Defense response 448 4 Saa3, Apoa4, Hamp2, Serpina3n
Acute-phase
response
30 2 Saa3, Serpina3n
GO gene ontology, FDR false discovery rate using a Benjamini and Hochberg multip
value modified Fisher’s exact P value calculated by DAVID softwareplasma apolipoprotein that functions as a satiety factor and
anti-inflammatory protein. Intestinal APOA4 synthesis is
stimulated by fat intake and is attenuated by intravenous
leptin infusion, indicating a close association between fat
and energy intake [45]. Apoa4 expression is altered along
with that of other genes involved in epithelial junctional
integrity in the intestinal mucosa of patients with IBD
[46]. APOA4 stabilizes adherent junctions by interacting
with α-catenin and may be involved in the maintenance of
junctional integrity. Epithelial tight junctions form a
barrier to prevent the movement of pathogens, toxins, and
allergens from the intestinal lumen into the tissue,
and disruption of these tight junctions may play an
important role in the pathogenesis of gastrointestinal
diseases [47, 48].
Lipid phosphate phosphatase 3 (LPP3) encoded by
Ppap2b is an integral membrane glycoprotein that cata-
lyzes the dephosphorylation of several bioactive lipid
mediators, including lysophosphatidic acid, sphingosine
1-phosphate, and phosphatidic acid. Moreover, LPP3
functions as a cell-associated integrin ligand [49, 50]. A
recent study reported that LPP3 does not promote
tumor formation but amplifies β-catenin signaling and
cyclin-D1 activity to potentiate the growth of SW480
colon carcinoma [51]. Aberrant activation of PI3K/Akt/
mTOR and MAPK/ERK pathways may induce colon
tumor growth and progression by increasing β-catenin
and cyclin-D1 expression [52, 53].ter 4
P value FDR





le testing correction, Pop Hits number of genes for a particular GO term, P
Fig. 4 Virtual network analysis of the selected genes in cluster 4
Bae et al. Genes & Nutrition  (2016) 11:30 Page 9 of 12Carboxyl ester lipase (CEL) encoded by Cel is a 74-
kDa lipolytic enzyme that hydrolyzes cholesteryl esters,
triacylglycerol, phospholipids, and lysophospholipids [54,
55]. This enzyme is synthesized in acinar cells of the
pancreas and is stored in zymogen granules. Upon food
ingestion, CEL is released into the intestinal lumen
where it constitutes 1–5% of total proteins in the pan-
creatic juice [56]. CEL plays a significant role in catalyz-
ing the absorption of cholesteryl esters from the
intestinal lumen and in promoting the formation of large
chylomicron [57, 58]. A recent study reported that Cel-
knockout mice developed a mild diabetic phenotype
after the administration of 60% HFD [59]. Since insulin
resistance is a risk factor of colon cancer, differential ex-
pression of Cel in obese animals may be responsible for
the association of obesity with the pathophysiological
changes in the colon.
Clps encodes colipase that is secreted from the exo-
crine pancreas into the gastrointestinal tract [60]. Coli-
pase may interact with pancreatic triglyceride lipase tofacilitate the digestion of dietary fats. HFD-fed Clps−/−
mice develop hyperphagia, and procolipase performs
essential functions by regulating body weight set point
[61]. Also, Clps genetic variability is associated with
insulin secretory function in non-diabetic humans,
suggesting that Clps is a novel candidate gene associ-
ated with the development of type 2 diabetes [36].
Regulation of insulin secretion is important for meta-
bolic homeostasis in various tissues, including the
liver, adipose tissue, and colon [62]. Therefore, Clps
expression would be a potential early marker of the
development of obesity, insulin resistance, and/or
colon cancer.
Conclusions
In conclusion, our data indicate that a few genes primar-
ily involved in lipid metabolism play a functional role in
diet-induced pathological changes in the colon.
Genome-wide analyses performed in the present study
provide new insights on selecting novel genes that may
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Fig. 5 Comparison of log2 fold changes in gene expression detected by performing microarray and quantitative reverse transcription-PCR ana-
lyses. Microarray data are presented as log2-transformed mean fold changes (high-fat diet vs. normal diet) in gene expression at each time point.
The real-time qPCR data are shown as log2-transformed mean fold changes ± SEM of the RNA samples pooled from 10 mice per group (n = 3).
a Apoa4, apolipoprotein A-IV. b Ppap2b, phosphatidic acid phosphatase type 2B. c Cel, carboxyl ester lipase. d Clps, colipase, pancreatic
Bae et al. Genes & Nutrition  (2016) 11:30 Page 10 of 12be associated with the development of diseases of the
colon. Further studies assessing the functions of these
selected genes are necessary to verify them as novel bio-
markers for the prevention, early detection, and treat-
ment of obesity-induced CRC.Additional files
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